GPA and percentages are weighted by recorded letter grades. UW
comparisons use the same terms. Cross-listed courses count once within
this department and once across UW; department totals should not be
added together. Grade counts are not unique students. Offering counts
reflect captured records, not a complete historical schedule.
Spring 2027
Recorded this term
3434courses with offerings
5454instructors recorded
Grades have not been recorded for this term. Historical results remain
in the overview above.
Toxicology II surveys basic methods and biochemical mechanisms of toxicity, covering mammalian organ systems, evaluation techniques, species specificity, and environmental interactions.
Covers underlying science, pharmacological actions, and biological effects of drugs on human health, including treatments for common illnesses and commonly abused drugs.
Medicinal Chemistry I covers basic concepts in small molecule medicinal product chemistry, including structure-activity relationships for various drug classes and an overview of drug metabolism and genetic variability.
MEDICINAL CHEMISTRY II covers the chemistry of medicinal products including antihyperlipidemics, glucocorticoids, estrogens, progestins, NSAIDs, antitumor agents, and enzyme inhibitors.
A global history of psychedelics examining psychopharmacology, pharmaceuticals, the war on drugs, consumerism, class, ethnicity, gender, military history, laws, regulations, and drug biographies.
In-depth introduction to molecular and cellular pharmacology focusing on drug mechanisms, signaling pathways, second messengers, kinase cascades, and gene transcription regulation.
Explores neural mechanisms of serotonergic psychedelics' therapeutic effects, linking serotonin receptor actions to cellular, network, and behavioral outcomes within models of perception, cognition, and consciousness.
Examines the biological and pharmacological basis of substance dependence and prescribes potentially addictive agents, covering opioids, cannabinoids, psychedelics, amphetamines, and related substances.
Explores the science of psilocybin and LSD, covering medicinal chemistry, neuropharmacology, FDA approval, clinical research, and the history of regulation and indigenous use.
Senior seminar featuring student presentations of independent research or published papers, faculty-led sessions on responsible conduct of research, and career talks from alumni in diverse professional fields.
Advanced independent study involving directed projects arranged with faculty, focusing on executing hypothesis-driven research in pharmaceutical sciences.
Skills for Professional Success explores strategies for navigating key phases of the graduate student experience: transitioning into graduate school, the formation of professional identity, and charting post-graduation career pathways.
Introduction to Regulatory Practice examines key regulatory agencies and practices governing the pharmaceutical industry, highlighting FDA and ICH regulations and guidance for product development.
Applies project management theory, frameworks, and tools to the drug development process, covering lifecycle phases, scheduling, resource allocation, and risk management in pharmaceutical contexts.
Covers laboratory techniques and analytical instrumentation for drug discovery, including DNA, chromatography, cell culture, protein analysis, and mass spectrometry.
Introduction to Data Analyses in Drug Development covers data analysis techniques in drug discovery, focusing on project-based skills with industry-standard software and public databases.
Focuses on applying communication, interpersonal, and cultural competency skills to prepare for careers in scientific industries, synthesizing knowledge for professional aptitude.
Summative Research Internship integrates core coursework with a real-world project or internship to synthesize skills for pharmaceutical science careers.
Introduction to basic concepts of drug delivery and action, methods used to study drug action. Includes a brief survey of drugs acting on the cardiovascular system, the central nervous system and other drug targets.
Overview of drug development from discovery to IND, covering target identification, validation, hit-to-lead, CMC, pharmacology, pharmacokinetics, and toxicology for small and large molecules.
Overview of drug development from first-in-human to NDA/BLA submission, covering clinical phases, biomarkers, companion diagnostics, statistical analysis, CMC, and both small molecule and protein therapeutics.
Principles of Assay Development covers biochemical and spectrophotometric bases for molecular target assays, guiding selection of in vitro and cellular assays for drug development hypotheses.
CNS Drug Designs, Actions, and Applications II examines molecular and anatomical factors influencing drugs acting on GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.
Introduces synthetic and biological polymers applied for drug targeting and controlled drug release, focusing on injectable drugs, including biologics.